Vein Size and Disease Severity in Chronic Venous Diseases

N Radhakrishnan1, Deepu George1, R Jayakrishnan1,2

  • 1St.Thomas Institute of Research on Venous Diseases, Changanassery, Kerala, India.

Insights

Small varicose veins, even without large vein involvement, significantly increase the risk of severe chronic venous disease symptoms like edema and skin changes. This highlights the importance of considering smaller veins in patient screening for intervention.

Area of Science:

  • Vascular Medicine
  • Medical Diagnostics
  • Public Health

Background:

  • Chronic venous diseases (CVD) are highly prevalent, necessitating clear criteria for intervention.
  • Identifying patients requiring treatment for CVD often relies on assessing larger vein incompetence.

Purpose of the Study:

  • To evaluate the association between the size of affected veins and the severity of CVD.
  • To establish an acceptable criterion for identifying patients needing intervention based on vein size.

Main Methods:

  • Demographic data and risk factors were collected from 6350 patients.
  • Patients were classified using the clinical severity, etiology, anatomy, and pathophysiology (CEAP) system based on physical examination and venous duplex ultrasound.
  • Veins with varicosities were categorized by size: <4 mm diameter (type I) and >4 mm diameter (type II).
  • Multivariate regression analysis was used to determine risk ratios.

Main Results:

  • 47.67% of patients presented with CEAP class 3 disease.
  • Varicosities in smaller superficial veins (<4 mm) were associated with a 2.85-fold increased risk of edema and a 5.71-fold higher prevalence of hyperpigmentation compared to large truncal veins.
  • Small varicose veins showed a higher risk of ulceration (OR 3.93) than truncal vein reflux.

Conclusions:

  • The presence of small varicose veins, even without truncal saphenous vein reflux, is linked to severe venous insufficiency manifestations.
  • These include edema and skin lesions, indicating the clinical significance of smaller veins in CVD severity.

Related Concept Videos

Chronic Obstructive Pulmonary Disease01:24

Chronic Obstructive Pulmonary Disease

COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
2.5K
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
728
Chronic Obstructive Pulmonary Disease-I: Introduction01:20

Chronic Obstructive Pulmonary Disease-I: Introduction

Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
3.7K
Chronic Obstructive Pulmonary Disease-V: Management01:29

Chronic Obstructive Pulmonary Disease-V: Management

Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
3.2K
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
653
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
4.5K